[Skip to Navigation]
Sign In
August 3, 2022

Errors in a Figure

JAMA Surg. 2022;157(9):859. doi:10.1001/jamasurg.2022.3765

In the article titled “Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial,” published online June 23, 2021, in JAMA Surgery,1 the numbers of individuals at risk were given incorrectly in Figure 3. These errors did not affect the authors’ conclusions. The article has been corrected.1

Yang H, Liu H, Chen Y, et al. Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg. Published online June 23, 2021. doi:10.1001/jamasurg.2021.2373Crossref